Rapid viral response to treatment with pegylated (40KDA) interferon alfa-2a (Pegasys TM) is strongly predictive of a sustained virologic response in patients with chronic hepatitis C - Neumann,A.U.; Zeuzem,S.; Brunda,M.J. (Hepatology, 2000)